Absence of rapidly developing resistance during treatment of cystic fibrosis patients with aztreonam.

J. Allen,J. Bosso,B. Saxon,J. Matsen
DOI: https://doi.org/10.1016/0732-8893(87)90047-2
IF: 2.983
1987-09-01
Diagnostic Microbiology and Infectious Disease
Abstract:
What problem does this paper attempt to address?